微 信 题 库 搜 索
医学论文
期刊分类
国 家 级 省级期刊 北大核心
浙 江 省 科技核心 CSCD期刊
期刊工具
期刊知识 写作指导 论文投稿
论文检测 推荐期刊 录用通知
各省动态
北京 天津 河北
上海 湖北 江苏
浙江 安徽 更多省份
 医学全在线 > 医学论文 > SCI期刊 > 正文
Molecular cancer research
if:4.353 更新:2015/2/12 字体:

Molecular cancer research
影响因子: 4.353
I S S N: 1541-7786
出 版 社: American Association for Cancer Research
出 版 地: Philadelphia, PA
出版国家: United States
刊  期: 月刊
创刊时间: 2002
语  种: 英文
审稿周期: 偏慢,4-8周
中科院分区: 2
投稿命中率: 较易
国外数据库收录: IM
中国收录文章数: 20
5年影响因子: 4.49
研究领域: 细胞、分子生物学、肿瘤
官方链接: http://mcr.aacrjournals.org/
投稿须知: http://mcr.aacrjournals.org/

期刊介绍:

Molecular Cancer Research joins the circle of outstanding journals published by the American Association for Cancer Research: Clinical Cancer Research, Molecular Cancer Therapeutics, Cancer Epidemiology, Biomarkers, & Prevention, and, of course, the AACR's renowned, widely cited, and comprehensive general cancer journal, Cancer Research. If you or your colleagues wish to find a forum with a critical mass of information about the latest advances in molecular and cellular aspects of cancer biology, Molecular Cancer Research is a journal you should be reading regularly. If you are working in molecular and cellular biology, are focusing your studies on issues related to cancer, and have novel and well-designed research, Molecular Cancer Research is a journal you should consider for the publication of your work. Rapid and effective communication of scientific insights is key to optimal translation of discoveries. The goal for Molecular Cancer Research is to strengthen and accelerate the communication of important scientific information in molecular and cellular cancer biology. Toward that end, content is presented in new sections that reflect natural groupings of fields within cancer biology, each led by a distinguished Senior Editor, supported by a highly expert Editorial Board.
相关文章
 论文发表期刊在线查询操作步骤图文详解版
 2014年湖南高级职称评审论文正式期刊目录汇
 医学论文投稿官网注意事项汇总
 国家权威学术期刊参考名录
 重庆市临床医学专业高级职称申报条件(试行
 四川省合法期刊/A类期刊/B类期刊查询
   触屏版       电脑版       全站搜索       网站导航   
版权所有:医学全在线(m.med126.com)
网站首页
频道首页
在线咨询
返回顶部